AZN vs EPAC · P/E 28, $288.38B cap vs P/E 24, rev $616.9M
AstraZeneca PLC (AZN) versus Enerpac Tool Group Corp (EPAC) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Enerpac Tool Group Corp (EPAC) is a specialty industrial machinery company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported EPAC revenue for 2025-08-31 was $616.9M. Net income was $92.7M. EPAC currently screens at market cap $2.06B and trailing P/E 23.7.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. EPAC currently screens at market cap $2.06B and trailing P/E 23.7.
Not investment advice. Open the AZN and EPAC stock pages for the full models.
Not investment advice.